X
20
Korea United Pharm. Inc. Seoul Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Felodipine, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2006-099 - Rev 00
This Chemical Type CEP, issued on December 19, 2007, remains in force until January 22, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 1013 associated with this CEP further emphasizes